Season's Savings | ₹5/mo for 3 months
₹199/month after first 3 months. Renews automatically. Terms apply.
Could Your Ultrasound Miss Cancer? What Every Woman Needs to Know.
Failed to add items
Sorry, we are unable to add the item because your shopping basket is already at capacity.
Add to cart failed.
Please try again later
Add to wishlist failed.
Please try again later
Remove from wishlist failed.
Please try again later
Follow podcast failed
Unfollow podcast failed
-
Narrated by:
-
Written by:
About this listen
What if the test meant to reassure you… could actually miss cancer?
Bleeding after menopause is often the first—and sometimes only—warning sign of uterine cancer, yet new evidence shows the way we’ve been evaluating it may not be enough. In this must-listen episode, Dr. Stephanie Hack, MD, MPH breaks down the latest ACOG guidelines that are reshaping care, explaining why ultrasound alone can miss serious disease and what should happen instead.
If you’ve ever been told “everything looks normal,” or you care about a woman who has—this episode could change what happens next.
REFERENCES- ACOG Clinical Practice Update (2026): Updated Guidance Regarding the Role of Transvaginal Ultrasonography in Evaluating the Endometrium of Individuals With Postmenopausal Bleeding
- American Cancer Society: Endometrial Cancer Statistics
- https://www.cancer.org/cancer/types/endometrial-cancer/about/key-statistics.html
- AACR (American Association for Cancer Research): Uterine Cancer Projections
- https://www.aacr.org/about-the-aacr/newsroom/news-releases/u-s-uterine-cancer-incidence-and-mortality-rates-expected-to-significantly-increase-by-2050/
- NCBI/StatPearls: Endometrial Cancer Overview
- https://www.ncbi.nlm.nih.gov/books/NBK525981/
adbl_web_anon_alc_button_suppression_t1
No reviews yet